Efficacy of Mannitol and Hypertonic Saline for Different Types of Edema

Mechanism of Action and Critical Limitations

The American College of Medical Toxicology recommends that mannitol and hypertonic saline are effective primarily for vasogenic edema, not for all types of cerebral edema, with a strength of evidence level of high 1, 2
The mechanism of action of mannitol requires an intact blood-brain barrier to be effective, as it creates an osmotic gradient across the barrier, drawing fluid from the edematous cerebral tissue into the intravascular space 2

The American Academy of Neurology recommends mannitol for patients with vasogenic edema, such as those with intracerebral hemorrhage and mass effect, with a strength of evidence level of moderate 2
Hypertonic saline is also effective in these conditions, with a strength of evidence level of high 1, 2
Both agents work by mobilizing fluid from the intracellular space to the interstitial and intravascular spaces, with a coefficient of reflection of the cell membrane for sodium of 1.0, compared to 0.9 for mannitol 3
For cytotoxic edema, the coefficient of reflection of the endothelial membrane is only 0.1, resulting in most fluid mobilization occurring from the intracellular space, not the interstitial space, with a strength of evidence level of low 3
There is no specific evidence in the guidelines to support the effectiveness of mannitol or hypertonic saline for pure interstitial edema, with a strength of evidence level of very low 1, 2, 3

At equiosmolar doses (approximately 250 mOsm), mannitol and hypertonic saline have comparable efficacy for reducing intracranial pressure, with a strength of evidence level of high 1, 2
Mannitol is typically administered at 20% concentration, 0.25-1.0 g/kg, infused over 15-20 minutes, with a strength of evidence level of moderate 1
The serum osmolarity should be monitored to remain below 320 mOsm/L to prevent renal failure, with a strength of evidence level of high 1
The choice of agent depends on the presence of hypernatremia or the need to improve cerebral blood flow rheology, with mannitol being preferred, or hypovolemia or hypotension, with hypertonic saline being preferred, with a strength of evidence level of moderate 1, 2